SCHEMBL7064381

SCHEMBL7064381

COc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 10/20 0.65
AKR1C2 P52895 9/20 0.65
AKR1B10 O60218 1/20 0.65
AKR1B1 P15121 1/20 0.65
AKR1C4 P17516 1/20 0.65
AKR1C1 Q04828 1/20 0.65
FABP3 P05413 1/20 0.62
FABP4 P15090 1/20 0.62
CDC25B P30305 2/20 0.62
CLCN2 P51788 1/20 0.60
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 3/20 0.56
HPGD P15428 2/20 0.56
MAPT P10636 2/20 0.56
USP2 O75604 1/20 0.56
MT-CO2 P00403 1/20 0.56
TTR P02766 1/20 0.56
PLA2G1B P04054 1/20 0.56
CYP1A2 P05177 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6141423 0.87 AKR1C3 (0.70) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL14376023 0.86 AKR1C3 (0.82) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL22720189 0.85 AKR1C3 (0.71) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL6141457 0.84 AKR1C3 (0.70) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL21027769 0.84 CDC25B (0.63) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL10834828 0.82 AKR1C3 (0.67) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL31494629 0.82 AKR1C3 (0.67) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL24021597 0.81 AKR1C3 (0.64) AKR1C3AKR1C2AKR1B10AKR1B1AKR1C4
SCHEMBL16489012 0.81 EGFR (0.66) AKR1C3AKR1C2AKR1B10AKR1C1FABP3
SCHEMBL17363157 0.81 DHODH (0.69) CLCN2MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313696-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2003-05-28 EP disclosed
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors ABBOTT LABORATORIES 2002-03-21 US disclosed
WO-2002018323-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2002-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors PPM1A, PTPRO, PTP4A1 AKR1C3 1253/4885AKR1C2 886/4885AKR1B10 677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.